Cargando…
Long-Acting HIV Treatment and Prevention: Closer to the Threshold
Substantial progress has been made toward viable, practical long-acting approaches to deliver HIV treatment and prevention through: (1) continued improvements in long-acting antiretrovirals (ARVs); (2) better innovative delivery systems; and (3) collaboration of willing partners to advance new ARVs....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Global Health: Science and Practice
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487081/ https://www.ncbi.nlm.nih.gov/pubmed/28655797 http://dx.doi.org/10.9745/GHSP-D-17-00206 |
_version_ | 1783246388261289984 |
---|---|
author | Barnhart, Matthew |
author_facet | Barnhart, Matthew |
author_sort | Barnhart, Matthew |
collection | PubMed |
description | Substantial progress has been made toward viable, practical long-acting approaches to deliver HIV treatment and prevention through: (1) continued improvements in long-acting antiretrovirals (ARVs); (2) better innovative delivery systems; and (3) collaboration of willing partners to advance new ARVs. More progress on those 3 fronts is still needed to arrive at the goal of optimized HIV treatment and prevention for all who would benefit—and of finally controlling the HIV epidemic. |
format | Online Article Text |
id | pubmed-5487081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Global Health: Science and Practice |
record_format | MEDLINE/PubMed |
spelling | pubmed-54870812017-06-30 Long-Acting HIV Treatment and Prevention: Closer to the Threshold Barnhart, Matthew Glob Health Sci Pract Editorial Substantial progress has been made toward viable, practical long-acting approaches to deliver HIV treatment and prevention through: (1) continued improvements in long-acting antiretrovirals (ARVs); (2) better innovative delivery systems; and (3) collaboration of willing partners to advance new ARVs. More progress on those 3 fronts is still needed to arrive at the goal of optimized HIV treatment and prevention for all who would benefit—and of finally controlling the HIV epidemic. Global Health: Science and Practice 2017-06-27 /pmc/articles/PMC5487081/ /pubmed/28655797 http://dx.doi.org/10.9745/GHSP-D-17-00206 Text en © Barnhart. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit http://creativecommons.org/licenses/by/3.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-17-00206 |
spellingShingle | Editorial Barnhart, Matthew Long-Acting HIV Treatment and Prevention: Closer to the Threshold |
title | Long-Acting HIV Treatment and Prevention: Closer to the Threshold |
title_full | Long-Acting HIV Treatment and Prevention: Closer to the Threshold |
title_fullStr | Long-Acting HIV Treatment and Prevention: Closer to the Threshold |
title_full_unstemmed | Long-Acting HIV Treatment and Prevention: Closer to the Threshold |
title_short | Long-Acting HIV Treatment and Prevention: Closer to the Threshold |
title_sort | long-acting hiv treatment and prevention: closer to the threshold |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487081/ https://www.ncbi.nlm.nih.gov/pubmed/28655797 http://dx.doi.org/10.9745/GHSP-D-17-00206 |
work_keys_str_mv | AT barnhartmatthew longactinghivtreatmentandpreventionclosertothethreshold |